Analysis of the Relationship Between Metalloprotease-9 and Tau Protein in Alzheimer’s Disease
- 21 July 2020
- journal article
- research article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 76 (2) , 553-569
Abstract
Background: Neurofibrillary tangles (NFTs) and amyloid plaques are the neuropathological hallmarks in brains with Alzheimer’s disease (AD). Post-translational modifications of tau, such as phosphorylation and truncation, have been proposed as initiatKeywords
This publication has 52 references indexed in Scilit:
- Hippocampal CA1 apical neuropil atrophy and memory performance in Alzheimer's diseaseNeuroImage, 2012
- OPM database and PPM web server: resources for positioning of proteins in membranesNucleic Acids Research, 2011
- TmoleX—A graphical user interface for TURBOMOLEJournal of Computational Chemistry, 2010
- I-TASSER: a unified platform for automated protein structure and function predictionNature Protocols, 2010
- Increased Matrix Metalloproteinase 9 Activity in Mild Cognitive ImpairmentJournal of Neuropathology & Experimental Neurology, 2009
- Tau fragmentation, aggregation and clearance: the dual role of lysosomal processingHuman Molecular Genetics, 2009
- Scalable molecular dynamics with NAMDJournal of Computational Chemistry, 2005
- All-Atom Empirical Potential for Molecular Modeling and Dynamics Studies of ProteinsThe Journal of Physical Chemistry B, 1998
- VMD: Visual molecular dynamicsJournal of Molecular Graphics, 1996
- A metalloproteinase inhibitor domain in Alzheimer amyloid protein precursorNature, 1993